154 related articles for article (PubMed ID: 3495543)
1. The Ha-ras-induced transformed phenotype of rat-1 cells can be suppressed in hybrids with rat embryonic fibroblasts.
Willecke K; Griegel S; Martin W; Traub O; Schäfer R
J Cell Biochem; 1987 May; 34(1):23-30. PubMed ID: 3495543
[TBL] [Abstract][Full Text] [Related]
2. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts.
Griegel S; Traub O; Willecke K; Schäfer R
Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793
[TBL] [Abstract][Full Text] [Related]
3. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
4. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
8. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
9. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
11. The normal human H-ras1 gene can act as an onco-suppressor.
Spandidos A; Wilkie NM
Br J Cancer Suppl; 1988 Dec; 9():67-71. PubMed ID: 3076068
[TBL] [Abstract][Full Text] [Related]
12. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
13. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes.
Spandidos DA; Frame M; Wilkie NM
Anticancer Res; 1990; 10(6):1543-54. PubMed ID: 2285227
[TBL] [Abstract][Full Text] [Related]
14. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression.
Reeder MK; Isom HC
Cell Growth Differ; 1996 Apr; 7(4):449-60. PubMed ID: 9052986
[TBL] [Abstract][Full Text] [Related]
15. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype.
Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS
J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130
[TBL] [Abstract][Full Text] [Related]
16. Analysis of myogenesis by somatic cell hybridization. II. Retention of myogenic competence and suppression of transformed properties in hybrids between differentiation competent and incompetent rat L6 myoblasts.
Lawrence JB; Coleman JR
J Cell Physiol; 1983 Jan; 114(1):99-110. PubMed ID: 6826666
[TBL] [Abstract][Full Text] [Related]
17. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
20. Functional identification and molecular cloning of a rat gene mediating growth inhibition and programmed cell death in normal and transformed rat cell lines.
Schwarte-Waldhoff I; Martin W; Willecke K; Schäfer R
Oncogene; 1994 Mar; 9(3):899-909. PubMed ID: 8108134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
